TG Therapeutics, Inc. (TGTX)
61.18
+3.10
(+5.34%)
USD |
NASDAQ |
Oct 30, 16:00
61.64
+0.46
(+0.75%)
Pre-Market: 20:00
TG Therapeutics 30-Day Average Daily Volume : 1.609M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.609M |
| October 29, 2026 | 1.686M |
| October 28, 2026 | 1.676M |
| October 27, 2026 | 1.723M |
| October 26, 2026 | 1.732M |
| October 23, 2026 | 1.738M |
| October 22, 2026 | 1.718M |
| October 21, 2026 | 1.720M |
| October 20, 2026 | 1.728M |
| October 19, 2026 | 1.729M |
| October 16, 2026 | 1.710M |
| October 15, 2026 | 1.704M |
| October 14, 2026 | 1.722M |
| October 13, 2026 | 1.786M |
| October 12, 2026 | 1.806M |
| October 09, 2026 | 1.816M |
| October 08, 2026 | 1.802M |
| October 07, 2026 | 1.777M |
| October 06, 2026 | 1.793M |
| October 05, 2026 | 1.807M |
| October 02, 2026 | 1.941M |
| October 01, 2026 | 1.967M |
| September 30, 2026 | 1.939M |
| September 29, 2026 | 1.916M |
| September 28, 2026 | 1.897M |
| Date | Value |
|---|---|
| September 25, 2026 | 1.885M |
| September 24, 2026 | 1.934M |
| September 23, 2026 | 1.963M |
| September 22, 2026 | 1.942M |
| September 21, 2026 | 1.937M |
| September 18, 2026 | 1.924M |
| September 17, 2026 | 1.799M |
| September 16, 2026 | 1.845M |
| September 15, 2026 | 1.862M |
| September 14, 2026 | 2.017M |
| September 11, 2026 | 2.055M |
| September 10, 2026 | 2.104M |
| September 09, 2026 | 2.156M |
| September 08, 2026 | 2.186M |
| September 04, 2026 | 2.206M |
| September 03, 2026 | 2.221M |
| September 02, 2026 | 2.267M |
| September 01, 2026 | 2.233M |
| August 31, 2026 | 2.176M |
| August 28, 2026 | 2.156M |
| August 27, 2026 | 2.236M |
| August 26, 2026 | 2.268M |
| August 25, 2026 | 2.290M |
| August 24, 2026 | 2.291M |
| August 21, 2026 | 2.261M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.263M |
| Krystal Biotech, Inc. | 262175.4 |
| Regeneron Pharmaceuticals, Inc. | 753586.4 |
| SELLAS Life Sciences Group, Inc. | 6.172M |
| Travere Therapeutics, Inc. | 1.984M |